Terbinafine Hydrochloride Tablets, 250 mg
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Fasting
Conditions
Fasting
Trial Timeline
Jan 1, 2002 → Mar 1, 2002
NCT ID
NCT01286688About Terbinafine Hydrochloride Tablets, 250 mg
Terbinafine Hydrochloride Tablets, 250 mg is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Fasting. The current trial status is completed. This product is registered under clinical trial identifier NCT01286688. Target conditions include Fasting.
Hype Score Breakdown
Clinical
6
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01286688 | Phase 1 | Completed |
| NCT01286701 | Phase 1 | Completed |
Competing Products
20 competing products in Fasting